Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Thrombopoietin protects hematopoietic stem cells from retrotransposon-mediated damage by promoting an antiviral response.

Barbieri D, Elvira-Matelot E, Pelinski Y, Genève L, de Laval B, Yogarajah G, Pecquet C, Constantinescu SN, Porteu F.

J Exp Med. 2018 May 7;215(5):1463-1480. doi: 10.1084/jem.20170997. Epub 2018 Apr 3.

PMID:
29615469
2.

Age-Associated Decrease of the Histone Methyltransferase SUV39H1 in HSC Perturbs Heterochromatin and B Lymphoid Differentiation.

Djeghloul D, Kuranda K, Kuzniak I, Barbieri D, Naguibneva I, Choisy C, Bories JC, Dosquet C, Pla M, Vanneaux V, Socié G, Porteu F, Garrick D, Goodhardt M.

Stem Cell Reports. 2016 Jun 14;6(6):970-984. doi: 10.1016/j.stemcr.2016.05.007.

3.

IER3 supports KRASG12D-dependent pancreatic cancer development by sustaining ERK1/2 phosphorylation.

Garcia MN, Grasso D, Lopez-Millan MB, Hamidi T, Loncle C, Tomasini R, Lomberk G, Porteu F, Urrutia R, Iovanna JL.

J Clin Invest. 2014 Nov;124(11):4709-22. doi: 10.1172/JCI76037. Epub 2014 Sep 24.

4.

Interleukin-18 produced by bone marrow-derived stromal cells supports T-cell acute leukaemia progression.

Uzan B, Poglio S, Gerby B, Wu CL, Gross J, Armstrong F, Calvo J, Cahu X, Deswarte C, Dumont F, Passaro D, Besnard-Guérin C, Leblanc T, Baruchel A, Landman-Parker J, Ballerini P, Baud V, Ghysdael J, Baleydier F, Porteu F, Pflumio F.

EMBO Mol Med. 2014 Jun;6(6):821-34. doi: 10.1002/emmm.201303286. Epub 2014 Apr 6.

5.

Thrombopoietin promotes NHEJ DNA repair in hematopoietic stem cells through specific activation of Erk and NF-κB pathways and their target, IEX-1.

de Laval B, Pawlikowska P, Barbieri D, Besnard-Guerin C, Cico A, Kumar R, Gaudry M, Baud V, Porteu F.

Blood. 2014 Jan 23;123(4):509-19. doi: 10.1182/blood-2013-07-515874. Epub 2013 Nov 1.

6.

Thrombopoietin-increased DNA-PK-dependent DNA repair limits hematopoietic stem and progenitor cell mutagenesis in response to DNA damage.

de Laval B, Pawlikowska P, Petit-Cocault L, Bilhou-Nabera C, Aubin-Houzelstein G, Souyri M, Pouzoulet F, Gaudry M, Porteu F.

Cell Stem Cell. 2013 Jan 3;12(1):37-48. doi: 10.1016/j.stem.2012.10.012. Epub 2012 Dec 13.

7.

ERK1 regulates the hematopoietic stem cell niches.

Saulnier N, Guihard S, Holy X, Decembre E, Jurdic P, Clay D, Feuillet V, Pagès G, Pouysségur J, Porteu F, Gaudry M.

PLoS One. 2012;7(1):e30788. doi: 10.1371/journal.pone.0030788. Epub 2012 Jan 30.

8.

p-ERK1/2 is a predictive factor of response to erythropoiesis-stimulating agents in low/int-1 myelodysplastic syndromes.

Frisan E, Pawlikowska P, Pierre-Eugène C, Viallon V, Gibault L, Park S, Mayeux P, Dreyfus F, Porteu F, Fontenay M.

Haematologica. 2010 Nov;95(11):1964-8. doi: 10.3324/haematol.2010.024349. Epub 2010 Sep 7.

9.

The MAPK ERK1 is a negative regulator of the adult steady-state splenic erythropoiesis.

Guihard S, Clay D, Cocault L, Saulnier N, Opolon P, Souyri M, Pagès G, Pouysségur J, Porteu F, Gaudry M.

Blood. 2010 May 6;115(18):3686-94. doi: 10.1182/blood-2009-09-242487. Epub 2010 Mar 11.

10.

Gfi-1B promoter remains associated with active chromatin marks throughout erythroid differentiation of human primary progenitor cells.

Laurent B, Randrianarison-Huetz V, Kadri Z, Roméo PH, Porteu F, Duménil D.

Stem Cells. 2009 Sep;27(9):2153-62. doi: 10.1002/stem.151.

11.

Inhibition of B56-containing protein phosphatase 2As by the early response gene IEX-1 leads to control of Akt activity.

Rocher G, Letourneux C, Lenormand P, Porteu F.

J Biol Chem. 2007 Feb 23;282(8):5468-77. Epub 2007 Jan 2.

12.

B56-containing PP2A dephosphorylate ERK and their activity is controlled by the early gene IEX-1 and ERK.

Letourneux C, Rocher G, Porteu F.

EMBO J. 2006 Feb 22;25(4):727-38. Epub 2006 Feb 2.

13.

Thrombopoietin regulates IEX-1 gene expression through ERK-induced AML1 phosphorylation.

Hamelin V, Letourneux C, Romeo PH, Porteu F, Gaudry M.

Blood. 2006 Apr 15;107(8):3106-13. Epub 2005 Dec 20.

14.

The cancer chemopreventive agent resveratrol induces tensin, a cell-matrix adhesion protein with signaling and antitumor activities.

Rodrigue CM, Porteu F, Navarro N, Bruyneel E, Bracke M, Romeo PH, Gespach C, Garel MC.

Oncogene. 2005 May 5;24(20):3274-84.

PMID:
15735708
15.

Development of T-cell lymphomas in Emu-IEX-1 mice.

Zhang Y, Finegold MJ, Porteu F, Kanteti P, Wu MX.

Oncogene. 2003 Oct 9;22(44):6845-51.

PMID:
14534530
16.

Activation of the mitogen-activated protein kinases Erk1/2 by erythropoietin receptor via a G(i )protein beta gamma-subunit-initiated pathway.

Guillard C, Chrétien S, Pelus AS, Porteu F, Muller O, Mayeux P, Duprez V.

J Biol Chem. 2003 Mar 28;278(13):11050-6. Epub 2003 Jan 21.

17.

IEX-1: a new ERK substrate involved in both ERK survival activity and ERK activation.

Garcia J, Ye Y, Arranz V, Letourneux C, Pezeron G, Porteu F.

EMBO J. 2002 Oct 1;21(19):5151-63.

18.

Requirement for mitogen-activated protein kinase activation in the response of embryonic stem cell-derived hematopoietic cells to thrombopoietin in vitro.

Filippi MD, Porteu F, Le Pesteur F, Schiavon V, Millot GA, Vainchenker W, de Sauvage FJ, Dubart Kupperschmitt A, Sainteny F.

Blood. 2002 Feb 15;99(4):1174-82.

19.

Cloning and characterization of a family of proteins associated with Mpl.

Meunier C, Bordereaux D, Porteu F, Gisselbrecht S, Chrétien S, Courtois G.

J Biol Chem. 2002 Mar 15;277(11):9139-47. Epub 2002 Jan 9.

Supplemental Content

Loading ...
Support Center